Search
for
Sort by
Research 841–870 of 1000+
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- RAGE and Its Ligands in Melanoma
- Tumor Angiogenesis and Anti-angiogenic Therapy
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Corticosterone enhances the potency of ethanol against hippocampal long-term potentiation via local neurosteroid synthesis
- Symmetry breaking of tissue mechanics in wound induced hair follicle regeneration of laboratory and spiny mice
- AUTOLOGOUS FAT GRAFTING UPDATE. PRESENTATION OF OWN RESULTS IN FACIAL REGENERATION
- Treatment of Alopecia Areata With Tofacitinib
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Ritlecitinib in severe alopecia areata: a profile of its use
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Efficacy and safety of tofacitinib in patients with alopecia areata
- British Hair and Nail Society
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- New therapies for alopecia areata
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata